Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 7Rectal Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Stomach Neoplasms 2Neoplasm, Residual 2Mesothelioma, Malignant 2Uterine Cervical Neoplasms 1Turcot syndrome 1Solitary Fibrous Tumor, Pleural 1Sarcopenia 1Sarcoglycanopathies 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pancreatic Neuroendocrine Tumors (pNET) 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1NSCLC 1Microsatellite Instability 1Mesothelioma 1Melanoma 1Malnutrition 1Lung Neoplasms 1HER2 Negative Breast Cancer 1Glioblastoma 1Gastrointestinal Neoplasms 1Frailty 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1

Interventions

pembrolizumab 5Nivolumab 3durvalumab 2tremelimumab 1relatlimab 1fludarabine phosphate 1fludarabine 1avelumab 1atezolizumab 1Therapeutics 1Temozolomide 1Surgical Procedures, Operative 1Neoadjuvant Therapy 1Ipilimumab 1Injections 1Docetaxel 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Bevacizumab 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Microsatellite Instability × Chemotherapy, Adjuvant × 1 year × Clear all
NCT06646445 2025-06-13

PREMICES

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Turcot syndrome, Colonic Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡